- Shanghai Nianxing Industrial Co., Ltd
- China
- Product Name: Palmitic acid
- Price: Check
- Purity: 98.0%
- Stocking Period: 10 Day
- Contact: Yang
- Email: sales@echemcloud.com
- Nanjing Peptide Biotech Ltd
- China
- Product Name: LYS-LYS-ARG-ALA-ALA-ARG-ALA-THR-SER-NH2
- Price: ￥Inquiry/10g ￥Inquiry/100g ￥Inquiry/1kg ￥Inquiry/10kg
- Purity: 98.0%
- Stocking Period: 7 Day
- Contact: jom
- Email: chenglong.fan@njpeptide.com
- Dayang Chem (Hangzhou) Co., Ltd.
- China
- Product Name: H-LYS-LYS-ARG-ALA-ALA-ARG-ALA-THR-SER-NH2
- Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
- Purity: 98.0%
- Stocking Period: Inquiry
- Contact: Ms Wang
- Email: enquiry@dycnchem.com
- Taiwan Oyi peptide Co. Ltd
- China
- Product Name: LYS-LYS-ARG-ALA-ALA-ARG-ALA-THR-SER-NH2
- Price: $Inquiry/1mg $Inquiry/100kg
- Purity: 98.0%
- Stocking Period: 1 Day
- Contact: Vinnie
- Email: Jamie@api-made.com
119386-39-9
119386-39-9 structure
- Name: LYS-LYS-ARG-ALA-ALA-ARG-ALA-THR-SER-NH2
- Chemical Name: h-lys-lys-arg-ala-ala-arg-ala-thr-ser-nh2
- CAS Number: 119386-39-9
- Molecular Formula: C40H78N18O11
- Molecular Weight: 987.16100
- Catalog: Research Areas Cancer
- Create Date: 2018-11-22 12:42:33
- Modify Date: 2024-01-11 19:26:09
-
Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) is a substrate-specific peptide inhibitor of MLCK. Myosin light chain kinase fragment 11-19 amide inhibits hypotonicity-induced Ca2+ entry. Myosin light chain kinase fragment 11-19 amide can be used in the research of human cervical cancer[1][2].
| Name | h-lys-lys-arg-ala-ala-arg-ala-thr-ser-nh2 |
|---|---|
| Synonyms |
MYOSIN KINASE INHIBITING PEPTIDE
Myosin Light Chain Kinase Fragment 11-19 amide LYS-LYS-ARG-ALA-ALA-ARG-ALA-THR-SER-AMIDE LYS-LYS-ARG-ALA-ALA-ARG-ALA-THR-SER-NH2 KKRAARATS-NH2 myosin light chain kinase fragment 11-19 amide MYOSIN LIGHT CHAIN KINASE (11-19) AMIDE |
| Description | Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) is a substrate-specific peptide inhibitor of MLCK. Myosin light chain kinase fragment 11-19 amide inhibits hypotonicity-induced Ca2+ entry. Myosin light chain kinase fragment 11-19 amide can be used in the research of human cervical cancer[1][2]. |
|---|---|
| Related Catalog | |
| Target |
MLCK[1] |
| In Vitro | Myosin light chain kinase fragment 11-19 amide (5 μM) reduces the amplitude and rate of activation of noradrenaline-evoked non-selective cation current (Icat) in rabbit portal vein myocytes[1]. Myosin light chain kinase fragment 11-19 amide inhibits swelling-activated taurine transport with an IC50 value of 2.0 µM[2]. Myosin light chain kinase fragment 11-19 amide (10 µM) inhibits β2-integrin-mediated adhesion in neutrophils treated with KT5720 (25 µM)[3]. |
| Molecular Formula | C40H78N18O11 |
|---|---|
| Molecular Weight | 987.16100 |
| Exact Mass | 986.61000 |
| PSA | 518.21000 |
| LogP | 0.20500 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |